Kazia Therapeutics LTD (KZIA) — 424B3 Filings

All 424B3 filings from Kazia Therapeutics LTD. Browse 4 424B3 reports with AI-powered summaries and risk analysis.

424B3 Filings (4)

424B3 Filing — Apr 15, 2026
Kazia Therapeutics Files Prospectus Supplement — Apr 15, 2026 Risk: medium
Kazia Therapeutics Ltd. filed a prospectus supplement on April 15, 2026, related to its common stock. The filing details the terms of a proposed offering, thoug
Kazia Therapeutics Files Prospectus Supplement — Apr 15, 2026 Risk: medium
Kazia Therapeutics Ltd. filed a prospectus supplement on April 15, 2026, related to its common stock. The filing details the terms of a public offering, though
Kazia Therapeutics Files Prospectus Supplement — Apr 15, 2026 Risk: medium
Kazia Therapeutics Ltd. filed a prospectus supplement (424B3) on April 15, 2026, related to its securities. The filing originates from Sydney, Australia, with t

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX